ZNF185 and prostate carcinoma: Similarly, the reduced expression of FCMD, which was reported to be involved in brain development [33], and ZNF185, a tumor-suppressor protein associated with actin-cytoskeleton [34] and reported in prostate cancer, was observed in our studies.